Event Type
Disclosure
Voluntary
Variant
8-K
. Other Events On December 4, 2025, Intensity Therapeutics, Inc. (the “Company”) filed a prospectus supplement to increase the capacity of its existing “at-the
. Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 5.1 Opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. 23.1 Consent of Mint